Inherited cardiac diseases comprise a wide and heterogeneous spectrum of diseases of the heart, including the cardiomyopathies and the arrhythmic diseases in structurally normal hearts, that is, channelopathies. With a combined estimated prevalence of 3% in the general population, these conditions represent a relevant epidemiological entity worldwide, and are a major cause of cardiac morbidity and mortality in the young. The extraordinary progress achieved in molecular genetics over the last three decades has unveiled the complex molecular basis of many familial cardiac conditions, paving the way for routine use of gene testing in clinical practice. In current practice, genetic testing can be used in a clinically affected patient to confirm diagnosis, or to formulate a differential diagnosis among overlapping phenotypes or between hereditary and acquired (nongenetic) forms of disease. Although genotype-phenotype correlations are generally unpredictable, a precise molecular diagnosis can help predict prognosis in specific patient subsets and may guide management. In clinically unaffected relatives, genetic cascade testing is recommended, after the initial identification of a pathogenic variation, with the aim of identifying asymptomatic relatives who might be at risk of disease-related complications, including unexpected sudden cardiac death. Future implications include the identification of novel therapeutic targets and development of tailored treatments including gene therapy. This document reflects the multidisciplinary, 'real-world' experience required when implementing genetic testing in cardiomyopathies and arrhythmic syndromes, along the recommendations of various guidelines.

Girolami, F., Frisso, G., Benelli, M., Crotti, L., Iascone, M., Mango, R., et al. (2018). Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications. JOURNAL OF CARDIOVASCULAR MEDICINE, 19(1), 1-11 [10.2459/JCM.0000000000000589].

Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications

Crotti, L;
2018

Abstract

Inherited cardiac diseases comprise a wide and heterogeneous spectrum of diseases of the heart, including the cardiomyopathies and the arrhythmic diseases in structurally normal hearts, that is, channelopathies. With a combined estimated prevalence of 3% in the general population, these conditions represent a relevant epidemiological entity worldwide, and are a major cause of cardiac morbidity and mortality in the young. The extraordinary progress achieved in molecular genetics over the last three decades has unveiled the complex molecular basis of many familial cardiac conditions, paving the way for routine use of gene testing in clinical practice. In current practice, genetic testing can be used in a clinically affected patient to confirm diagnosis, or to formulate a differential diagnosis among overlapping phenotypes or between hereditary and acquired (nongenetic) forms of disease. Although genotype-phenotype correlations are generally unpredictable, a precise molecular diagnosis can help predict prognosis in specific patient subsets and may guide management. In clinically unaffected relatives, genetic cascade testing is recommended, after the initial identification of a pathogenic variation, with the aim of identifying asymptomatic relatives who might be at risk of disease-related complications, including unexpected sudden cardiac death. Future implications include the identification of novel therapeutic targets and development of tailored treatments including gene therapy. This document reflects the multidisciplinary, 'real-world' experience required when implementing genetic testing in cardiomyopathies and arrhythmic syndromes, along the recommendations of various guidelines.
Articolo in rivista - Articolo scientifico
arrhythmias; cardiomyopathies; genetic counselling; genetic testing; massive sequencing;
arrhythmias, cardiomyopathies, genetic counselling, genetic testing, massive sequencing
English
2018
2018
19
1
1
11
reserved
Girolami, F., Frisso, G., Benelli, M., Crotti, L., Iascone, M., Mango, R., et al. (2018). Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications. JOURNAL OF CARDIOVASCULAR MEDICINE, 19(1), 1-11 [10.2459/JCM.0000000000000589].
File in questo prodotto:
File Dimensione Formato  
Girolami 2018.pdf

Solo gestori archivio

Dimensione 269.66 kB
Formato Adobe PDF
269.66 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/189262
Citazioni
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 44
Social impact